Skip to content
BOLUS

Fund

Eli Lilly and Company

Page built from the operations logged, not from a written profile. It says nothing about the fund's activity outside the scope of Bolus, which is health venture capital in Europe and the United States.

Operations logged
9
Lead
0
New entries
7
Follow ons
2
Latest operation
24 September 2026
Sectors
Biotech

Operations

Date Company Stage Amount Role
24 Sept

United States, Biotech

Series C 75 M$ Existing investor
16 Sept

United States, Biotech

Series D and later 92,5 M$ Participant
15 Sept

United States

Undisclosed 108 M$ Participant
09 Sept

United States, Biotech

50 M$ Participant
09 Sept

United States, Biotech

Seed 33 M$ Participant
08 Sept

United States, Biotech

Series B 70 M$ Participant
03 Sept

United States, Biotech

Series B 60 M$ Existing investor
17 Aug

United States, Biotech

Series A 30 M$ Participant
12 Aug

United States

Series B 77 M$ Participant
Co investors 59 funds crossed

Funds that appeared in the same rounds, in any capacity. Geographies logged: United States.

One address, nothing else.

One letter a week, on Fridays: the week's funding rounds, the funds named, the amounts double checked. The list is never sold, one click to unsubscribe. The letter is written in French.

Email confirmation before any subscription. The list is never sold. What Bolus knows about you is written on the privacy page (in French).